医学
特发性肺纤维化
物理疗法
DLCO公司
肺功能测试
结节病
临床终点
阶段(地层学)
肺康复
肺活量
观察研究
生活质量(医疗保健)
内科学
扩散能力
肺
肺功能
随机对照试验
康复
古生物学
护理部
生物
作者
Bert Strookappe,Marjon Elfferich,Jeff Swigris,A.C. Verschoof,Johny Veschakelen,Ton Knevel,Marjolein Drent
出处
期刊:PubMed
日期:2015-06-22
卷期号:32 (1): 43-52
被引量:27
摘要
The natural history of disease in patients with stage IV (fibrotic) sarcoidosis may mirror that of patients with idiopathic pulmonary fibrosis (IPF). Both are bothered by progressive dyspnea, exercise limitation and fatigue.To establish whether patients suffering from pulmonary fibrosis might benefit from a physical training program.Twenty-four eligible patients referred to the out-patient clinic of the ild care expertise team of Hospital Gelderse Vallei, Ede, The Netherlands between November 2012 and November 2013 were included in this observational pilot study of a 12-week physical training program. Outcomes, including exercise capacity, skeletal muscle strength, lung function and fatigue were assessed at two time points: 1) baseline; and 2) after completion of a 12-week physical training program.At baseline, the percentage predicted DLCO, FVC, FEV1 and exercise capacity (assessed by six-minute walking distance (6MWD) or maximal oxygen uptake) was reduced in both groups. After program completion, exercise capacity improved (>10% improvement 6MWD) in 13 subjects (54.2%): 7 with IPF and 6 with sarcoidosis subjects. Other secondary endpoints, including pulmonary function tests and patient-reported outcome measures improved in some subjects.A 12-week physical training program improved or maintained exercise capacity in patients with IPF (despite disease progression) or fibrotic sarcoidosis. The results from this pilot study could be used to design prospective studies aimed at answering lingering questions about exercise training in patients with these progressive, incurable conditions.
科研通智能强力驱动
Strongly Powered by AbleSci AI